HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Anoxia (Hypoxia)

Relatively complete absence of oxygen in one or more tissues.
Also Known As:
Hypoxia; Hypoxemia; Anoxemia; Deficiency, Oxygen; Anoxemias; Anoxias; Deficiencies, Oxygen; Hypoxemias; Hypoxias; Oxygen Deficiencies; Oxygen Deficiency
Networked: 50851 relevant articles (1764 outcomes, 5603 trials/studies) for this Disease, Comments

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Ischemia
3. Pulmonary Hypertension (Ayerza Syndrome)
4. Anoxia (Hypoxia)
5. Hypercapnia

Experts

1. Harris, Adrian L: 120 articles (01/2014 - 02/2002)
2. Semenza, Gregg L: 115 articles (01/2014 - 01/2002)
3. Ratcliffe, Peter J: 82 articles (07/2013 - 01/2002)
4. Johnson, Randall S: 78 articles (11/2013 - 03/2002)
5. Giaccia, Amato J: 66 articles (10/2013 - 01/2002)
6. Simon, M Celeste: 64 articles (11/2013 - 04/2002)
7. Prabhakar, Nanduri R: 62 articles (11/2013 - 01/2002)
8. Gassmann, Max: 61 articles (12/2013 - 01/2002)
9. Harris, A L: 61 articles (08/2013 - 01/2000)
10. Schofield, Christopher J: 55 articles (07/2013 - 06/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Anoxia:
1. OxygenIBA
01/01/2013 - "After cold acclimation, susceptibility to hypoxia was not significantly different between the groups, while HCVR significantly increased in Groups 1 and 3, HVR significantly increased in Group 3 and HCVR, HVR did not change in Group 2. Short-term cold exposures caused an increase in functional reserves and improved oxygen supply of tissues in Group 1. Cold exposure hypoxia has caused energy loss in Group 3. Group 2 showed the most appropriate energy conservation reaction mode to cold exposures. "
11/01/2009 - "We found that (1) in contrast to oxygen partial pressure in blood (P(a)O(2)), the baseline value of P(t)O(2) in summer euthermic AGS is significantly higher than in rats; (2) both P(t)O(2) and P(a)O(2) are dramatically reduced by inspired 8% O(2) in AGS and rats, but AGS have a greater capacity in P(t)O(2) to cope with environmental hypoxia; (3) metabolic rate before, during, and after hypoxic exposure is consistently lower in AGS than in rats; (4) the respiratory responding patterns to hypoxia in the two species differ in that f(R) decreases in AGS but increases in rats. "
09/13/2004 - "Acute hypoxia reduced the median oxygen partial pressure (pO(2)) dramatically (1 vs 10 mmHg in controls), whereas in chronically hypoxic tumours the pO(2) was significantly improved (median pO(2)=4 mmHg), however not reaching the control level. "
07/04/1977 - "Portacaval transposition and end-to-side shunt led to a striking oxygen deficit of the liver tissue with no incidence of compensation by the hepatic artery; Oxygen supply was improved considerably by a side-to-side shunt and tissue hypoxia could be prevented by a mesenterico-caval shunt and splenocaval shunt. "
01/01/1995 - "Measurement of cardiac output and clinical assessment of the patients' oxygen requirements will complete the macro picture of supply and demand and although computed indicators of hypoxia have been improved in recent years (1, 2) the definitive diagnosis of histohypoxia requires the measurement of the cellular and subcellular products of metabolic processes that are present when an inappropriate concentration of oxygen has been experienced. "
Order ALL the reference details at left...
2. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
3. Adenosine Triphosphate (ATP)IBA
4. Glucose (Dextrose)FDA LinkGeneric
5. Nitric Oxide (Nitrogen Monoxide)FDA Link
6. Carbon MonoxideIBA
7. AdenosineFDA LinkGeneric
8. Lactic AcidFDA LinkGeneric
9. Glutamic Acid (Glutamate)FDA Link
10. Messenger RNA (mRNA)IBA

Therapies and Procedures

1. Radiotherapy
2. Drug Therapy (Chemotherapy)
3. Positive-Pressure Respiration (PEEP)
4. Artificial Respiration (Mechanical Ventilation)
5. Resuscitation

blog comments powered by Disqus
TREATMENT OPTIONS
for Anoxia,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 1764 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>